ClinicalTrials.gg
RecruitingNCT06777875Updated Nov 20, 2026

COMT and OPRM1 Polymorphisms and Their Effect on Post-Operative Pain in Children

An observational study in Pain, Genetic Change and Children, Only, sponsored by American University of Beirut Medical Center. Recruiting at 1 site in Lebanon. Open to participants aged 8 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by American University of Beirut Medical Center · Observational

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
8 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Pain with a site in Lebanon — 3 open to participants now, 6 under way, none of them phase 3. Pain · Lebanon.

Started
2025
with 5 others
Observational
Only one
of the 21
Registered
15th of 21
by date
Lead sponsor
6 of 21
American University of Beirut Medical Center

Among the 21 studies in Pain with a site in Lebanon, this one is one of 6 that started in 2025, is the only observational one, and was the 15th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

3 of the 21 studies in Pain with a site in Lebanon are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Lebanon have not opened yet or have stopped. Only those recruiting at a site in Lebanon →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 8 Years to 18 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Pain with a site in Lebanon, or all of them as a file.
02

Study summary

The goal of this observational study is to investigate whether the A118G single-nucleotide polymorphism (SNP) in the mu-opioid receptor1(OPRM1) and Catechol-O-methyltransferase (COMT) SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries.

The main question[s] it aims to answer [is]:

Do OPRM1 and COMT SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries?

Participants will be assessed for their pain scores, sedation level, the amount of postoperative analgesics received, duration of their stay in the post-anesthesia care unit, and toxicity.

Read the detailed description

Inadequately treated pain in children undergoing surgery is a major concern for health providers. Recent evidence indicates that pain sensitivity differs among races and ethnicities and genetic makeup. Catechol-O-methyltransferase (COMT) polymorphisms (rs6269, rs4633, rs4818 and rs4680) which are inherited together in different phenotypes influence clinical presentations and responses to pain.

A118G single-nucleotide polymorphism (SNP) in the mu-opioid receptor1 (OPRM1) gene is associated with differences in pain perception and opioid requirements. The effect of genome variations in the COMT gene and in the OPRM1 on postoperative pain perception and morphine analgesia in children needs further exploration. The main objective of this study was to investigate whether the OPRM1 and COMT SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries. Secondary objective includes assessing whether OPRM1 and COMT SNPs influence postoperative sedation score, intraoperative and postoperative opioid requirements, length of stay in the post anesthesia care unit (PACU), and signs of respiratory depression (RD) and postoperative nausea and vomiting (PONV).

Methodology: A prospective cohort genotype-blinded observational study will be conducted. A convenience sample of 200 children between the ages of 8-18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries will be recruited from the American University of Beirut Medical Center (AUBMC). The primary outcome of the study is the post operative pain score in PACU.

Secondary outcomes include the postoperative sedation score, intraoperative and postoperative opioid requirements, length of stay in the PACU, and signs of RD and PONV. To test the hypothesis that COMT and OPRM1 SNPs are associated with postoperative analgesia outcomes in children, SPSS version 29 will be used. Allelic and genotype frequencies will be examined by the Hardy-Weinberg equilibrium (HWE) test. To analyze the association between the different genetic variations and the outcomes, bivariate analysis will be performed. Variables measured over time will be compared between the groups using an exploratory mixed model analysis. Time to first post-operative opioid requirement will be analyzed using the survival analysis Kaplan Meier curve. Such understanding will pave the way for individual tailoring and optimization of pain assessment and management in children undergoing orthopedic, abdominal, thoracic, and plastic surgical procedures.

03

Conditions studied

  • Pain
  • Genetic Change
  • Children, Only

Browse trials for

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Children between the ages of 8-18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries will be recruited from the American University of Beirut Medical Center (AUBMC).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All children 8 years to 18 years
  • Undergoing orthopedic, abdominal, thoracic, and plastic surgeries
  • classification (ASA) I-II-III

Exclusion criteria

Exclusion Criteria:

  • Children with schizoid personality disorders, phobias, and anxiety
  • Patients with neuropathic pain associated with surgeries requiring surgical treatment.
  • Children presented with all types of depressive disorders, atypical bipolar disorder, or a suspicion of substance abuse.
  • classification (ASA) ≥IV
  • All patients receiving regional anesthesia, local blocks, epidural and caudal blocks.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Pain scores

    Pain scores measured using the Numerical Rating Scale (NRS) (ranging from 0 to 10, with 0 no pain and 10 worst pain)

    Time frame: Until discharge from PACU (about 3 hours)

Secondary outcomes

  1. Postoperative sedation

    Postoperative sedation measured using the Richmond Agitation Sedation Scale (RASS) (ranging from -5 to +4, with -5 unarousable and +4 combative)

    Time frame: Until discharge from PACU (about 3 hours)

  2. Use of intraoperative and post-operative opioids

    Use of intraoperative and post-operative opioids (Yes/No)

    Time frame: Until discharge from PACU (about 3 hours)

  3. Length of post-anesthesia care unit (PACU) stay

    Length of post-anesthesia care unit (PACU) stay measured in hours

    Time frame: Until discharge from PACU (about 3 hours)

  4. Postoperative respiratory depression

    Postoperative respiratory depression (Yes/No)

    Time frame: Until discharge from PACU (about 3 hours)

  5. Postoperative nausea and vomiting

    Postoperative nausea and vomiting (Yes/No)

    Time frame: Until discharge from PACU (about 3 hours)

07

Study locations

1 of 1 sites recruiting
  • Roland Kaddoum
    Beirut, Lebanon
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Jan 2027, 22 months after the start.

Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's planned 22 months is above that.

Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2025
First posted
Jan 16, 2025
StartActual
Mar 10, 2025
Primary completionEst.
Jan 13, 2027
CompletionEst.
Jan 13, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and site details
1 update, last Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Minor edits only
    + 2 other changes: verification date and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06777875
Responsible party
Roland Kaddoum (Principal Investigator, American University of Beirut Medical Center) — Principal investigator
First posted
Jan 16, 2025
Start date
Mar 10, 2025
Primary completion
Jan 13, 2027 (estimated)
Completion
Jan 13, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Roland Kaddoum, MD
Contact
rk16@aub.edu.lb
01350000 ext. 6380
Thouraya HajAli
Contact
th64@aub.edu.lb
01350000 ext. 5738
Roland Kaddoum, MD
principal investigator · American University of Beirut Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion